UniProt/SwissProt ID: | RAF1_HUMAN |
Description: | v-raf-1 murine leukemia viral oncogene homolog 1 [Source:HGNC Symbol;Acc:9829] |
Location: | chr3 p25.2 |
Node attribute: | PPI(source); substrate; kinase; effector; PPI(target) |
Phosphorylation site |
Position | PhosphoPeptide | Catalytic kinase | Source |
---|---|---|---|
S301 | SPNNLsPTGWS | PhosphoSitePlus; phosphoELM; RegPhos | |
T303 | NNLSPtGWSQP | PhosphoSitePlus; HPRD | |
S259 | RQRSTsTPNVH | AKT1 | HPRD; RegPhos; SysPTM |
S244 | TFNTSsPSSEG | PhosphoSitePlus; HPRD; SysPTM | |
S306 | SPTGWsQPKTP | PhosphoSitePlus | |
S289 | HSESAsPSALS | PhosphoSitePlus; phosphoELM; RegPhos | |
S43 | YQRRAsDDGKL | PhosphoSitePlus; RegPhos; SysPTM | |
S220 | RRMREsVSRMP | PhosphoSitePlus | |
S497 | VKSRWsGSQQV | Pkinase_Tyr | PhosphoSitePlus |
T213 | ALPSLtMRRMR | PhosphoSitePlus | |
S285 | AIRSHsESASP | PhosphoSitePlus | |
T362 | SGSFGtVYKGK | Pkinase_Tyr | PhosphoSitePlus |
S619 | PKINRsASEPS | PhosphoSitePlus; HPRD | |
T310 | WSQPKtPVPAQ | PhosphoSitePlus | |
S259 | RQRSTsTPNVH | PRKACA | HPRD; SysPTM |
S471 | HRDMKsNNIFL | Pkinase_Tyr | PhosphoSitePlus |
S43 | YQRRAsDDGKL | PRKACA | HPRD; SysPTM |
S339 | GQRDSsYYWEI | PhosphoSitePlus; HPRD; RegPhos | |
S289 | HSESAsPSALS | MAPK1 | HPRD |
T640 | NACTLtTSPRL | PhosphoSitePlus | |
T234 | QHRYStPHAFT | PhosphoSitePlus | |
S291 | ESASPsALSSS | PhosphoSitePlus; HPRD | |
S621 | INRSAsEPSLH | PKACa | RegPhos; SysPTM |
Y458 | AQGMDyLHAKN | Pkinase_Tyr | PhosphoSitePlus |
S257 | SQRQRsTSTPN | PhosphoSitePlus; HPRD; phosphoELM | |
S612 | ELLQHsLPKIN | PhosphoSitePlus | |
S642 | CTLTTsPRLP | phosphoELM; SysPTM | |
S471 | HRDMKsNNIFL | phosphoELM; RegPhos | |
T268 | VHMVStTLPVD | autocatalysis | RegPhos |
S296 | SALSSsPNNLS | PhosphoSitePlus; phosphoELM; RegPhos | |
T491 | DFGLAtVKSRW | HPRD; phosphoELM; RegPhos | |
S296 | SALSSsPNNLS | MAPK1 | HPRD |
S233 | SQHRYsTPHAF | PKACa | RegPhos |
T491 | DFGLAtVKSRW | Pkinase_Tyr | PhosphoSitePlus |
T324 | APVSGtQEKNK | PhosphoSitePlus | |
S43 | YQRRAsDDGKL | PKA_group | phosphoELM; RegPhos; SysPTM |
S259 | RQRSTsTPNVH | PhosphoSitePlus; HPRD; phosphoELM; SysPTM | |
Y341 | RDSSYyWEIEA | JAK2 | HPRD; RegPhos |
S338 | RGQRDsSYYWE | RHEB | HPRD |
S301 | SPNNLsPTGWS | MAPK1 | HPRD |
T481 | LHEGLtVKIGD | Pkinase_Tyr | PhosphoSitePlus |
S252 | SEGSLsQRQRS | PhosphoSitePlus; HPRD; phosphoELM; RegPhos | |
Y341 | RDSSYyWEIEA | PhosphoSitePlus | |
S621 | INRSAsEPSLH | AMPKa1 | RegPhos; SysPTM |
S621 | INRSAsEPSLH | RAF1 | HPRD; RegPhos; SysPTM |
S29 | GSSCIsPTIVQ | Erk2 | RegPhos |
S621 | INRSAsEPSLH | PRKAA1 | HPRD; SysPTM |
S338 | RGQRDsSYYWE | PhosphoSitePlus; phosphoELM | |
T258 | QRQRStSTPNV | PhosphoSitePlus; HPRD; phosphoELM | |
Y38 | VQQFGyQRRAS | PhosphoSitePlus | |
S29 | GSSCIsPTIVQ | MAPK1 | HPRD |
S43 | YQRRAsDDGKL | PKACa | RegPhos; SysPTM |
S283 | EDAIRsHSESA | PhosphoSitePlus | |
S642 | CTLTTsPRLPV | Erk2 | RegPhos; SysPTM |
S259 | RQRSTsTPNVH | PKACa | RegPhos; SysPTM |
T638 | DINACtLTTSP | PhosphoSitePlus | |
S259 | RQRSTsTPNVH | AMPK_group | RegPhos; SysPTM |
S296 | SALSSsPNNLS | Erk2 | RegPhos |
S294 | SPSALsSSPNN | PhosphoSitePlus; HPRD; phosphoELM; RegPhos | |
S259 | RQRSTsTPNVH | PKB_group | phosphoELM; SysPTM |
S233 | SQHRYsTPHAF | PRKACA | HPRD |
S357 | STRIGsGSFGT | Pkinase_Tyr | PhosphoSitePlus |
S233 | SQHRYsTPHAF | PhosphoSitePlus; phosphoELM; RegPhos | |
S301 | SPNNLsPTGWS | Erk2 | RegPhos |
S247 | TSSPSsEGSLS | PhosphoSitePlus | |
S499 | SRWSGsQQVEQ | PKCa | RegPhos |
S624 | SASEPsLHRAA | PhosphoSitePlus; HPRD | |
S621 | INRSAsEPSLH | AMPK_group | RegPhos; SysPTM |
T239 | TPHAFtFNTSS | PhosphoSitePlus | |
S621 | INRSAsEPSLH | PRKACA | HPRD; SysPTM |
S499 | SRWSGsQQVEQ | PRKCA | HPRD |
S339 | GQRDSsYYWEI | PAK1 | phosphoELM; RegPhos |
T269 | HMVSTtLPVDS | PhosphoSitePlus; HPRD; RegPhos | |
S289 | HSESAsPSALS | Erk2 | RegPhos |
S287 | RSHSEsASPSA | PhosphoSitePlus | |
S259 | RQRSTsTPNVH | AKT_group | RegPhos; SysPTM |
S499 | SRWSGsQQVEQ | PKC_group | phosphoELM; RegPhos |
T268 | VHMVStTLPVD | RAF1 | HPRD; RegPhos |
S259 | RQRSTsTPNVH | PKA_group | phosphoELM; RegPhos; SysPTM |
S295 | PSALSsSPNNL | PhosphoSitePlus; HPRD | |
S339 | GQRDSsYYWEI | SRC | HPRD |
S259 | RQRSTsTPNVH | PKC_group | RegPhos; SysPTM |
T260 | QRSTStPNVHM | PhosphoSitePlus; HPRD; phosphoELM | |
S642 | CTLTTsPRLP | MAPK1 | HPRD; SysPTM |
S338 | RGQRDsSYYWE | PAK2 | RegPhos |
S621 | INRSAsEPSLH | PKA_group | phosphoELM; RegPhos; SysPTM |
S338 | RGQRDsSYYWE | PAK_group | phosphoELM; RegPhos |
Y341 | RDSSYyWEIEA | Src | RegPhos |
T269 | HMVSTtLPVDS | KSR1 | phosphoELM; RegPhos |
Y341 | RDSSYyWEIEA | SRC | HPRD; phosphoELM; RegPhos |
Y340 | QRDSSyYWEIE | SRC | HPRD |
Y340 | QRDSSyYWEIE | PhosphoSitePlus; phosphoELM; RegPhos | |
S494 | LATVKsRWSGS | HPRD; phosphoELM; RegPhos | |
Y340 | QRDSSyYWEIE | JAK2 | HPRD; RegPhos |
S499 | SRWSGsQQVEQ | Pkinase_Tyr | PhosphoSitePlus |
S494 | LATVKsRWSGS | Pkinase_Tyr | PhosphoSitePlus |
S338 | RGQRDsSYYWE | SRC | HPRD |
S29 | GSSCIsPTIVQ | PhosphoSitePlus; phosphoELM; RegPhos | |
S338 | RGQRDsSYYWE | PAK3 | HPRD; phosphoELM; RegPhos |
S338 | RGQRDsSYYWE | PAK1 | HPRD; phosphoELM; RegPhos |
Y232 | SSQHRySTPHA | PhosphoSitePlus | |
S250 | PSSEGsLSQRQ | PhosphoSitePlus | |
S642 | CTLTTsPRLPV | PhosphoSitePlus; SysPTM | |
S621 | INRSAsEPSLH | PhosphoSitePlus; phosphoELM; RegPhos; SysPTM | |
T641 | ACTLTtSPRLP | HPRD | |
S211 | VPALPsLTMRR | PhosphoSitePlus | |
Dephosphorylation site |
Position | PhosphoPeptide | Catalytic kinase | Source |
---|---|---|---|
Y340 | RGQRDSSyYWEIEAS | CDC25A | HPRD |
Mutation site |
Ensembl ID | Variation | Source | Cancer name | Pubmed |
---|---|---|---|---|
ENSP00000251849 | Q335H | Greenman2007, HPI | Lung Cancer | 16140923, 17344846, 18428421 |
ENSP00000251849 | R495H | BIOMART | Pancreatic Cancer | 21930507, 21930502 |
ENSP00000251849 | A319S | Ding2008, BIOMART | Lung Cancer | 18948947, 21930507, 21930502 |
ENSP00000251849 | S259A | Greenman2007, HPI | Ovarian Cancer | 17344846, 18428421, 16630891, 17344846, 16630891 17344846 |
ENSP00000401888 | R515H | BIOMART | Pancreatic Cancer | 21930507, 21930502 |
Differential expressed protein |
Ensembl ID | Cancer name | Design | Sample | Change | Ratio | Pubmed |
---|---|---|---|---|---|---|
ENSP00000251849 | Neoplasms by Histologic Type | Treatment (none vs. SB203580 treatment 3 hour) | cell line | Down | 0.24 | 15169874 |
Hyperphosphorylation site |
Site | Motif | Peptide | Cancer name | Pubmed | Source |
---|---|---|---|---|---|
S259 | SQRQRSTsTPNVHMV | Alzheimer's disease | 17064357 | PhosphoSitePlus | |
S338 | RPRGQRDsSYYWEIE | Alzheimer's disease | 17064357 | PhosphoSitePlus | |
Y341 | GQRDSSYyWEIEASE | Alzheimer's disease | 17064357 | PhosphoSitePlus | |
Y340 | RGQRDSSyYWEIEAS | Alzheimer's disease | 17064357 | PhosphoSitePlus | |
S259 | SQRQRSTsTPNVHMV | 20679480 | PhosphoSitePlus | ||
Direct Interaction Pair |
Source | Target | Relationship | Resource |
---|---|---|---|
GBG1_HUMAN | RAF1_HUMAN | Gprotein -> effector | gpDB |
GBG13_HUMAN | RAF1_HUMAN | Gprotein -> effector | gpDB |
GBB2_HUMAN | RAF1_HUMAN | Gprotein -> effector | gpDB |
GBG2_HUMAN | RAF1_HUMAN | Gprotein -> effector | gpDB |
GBB3_HUMAN | RAF1_HUMAN | Gprotein -> effector | gpDB |
GBG10_HUMAN | RAF1_HUMAN | Gprotein -> effector | gpDB |
GBB1_HUMAN | RAF1_HUMAN | Gprotein -> effector | gpDB |
GBB5_HUMAN | RAF1_HUMAN | Gprotein -> effector | gpDB |
GBG12_HUMAN | RAF1_HUMAN | Gprotein -> effector | gpDB |
GBG3_HUMAN | RAF1_HUMAN | Gprotein -> effector | gpDB |
GBG5_HUMAN | RAF1_HUMAN | Gprotein -> effector | gpDB |
GBG11_HUMAN | RAF1_HUMAN | Gprotein -> effector | gpDB |
GBG8_HUMAN | RAF1_HUMAN | Gprotein -> effector | gpDB |
RAF1_HUMAN | CSRP3_HUMAN | kinase -> substrate | Robert H Newman (2013) |
RAF1_HUMAN | BAD_HUMAN | kinase -> substrate | KEGG |
RAF1_HUMAN | MP2K1_HUMAN | kinase -> substrate | RegPhos; Robert H Newman (2013) |
RAF1_HUMAN | AIRE_HUMAN | kinase -> substrate | Robert H Newman (2013) |
MK01_HUMAN | RAF1_HUMAN | kinase -> substrate | HPRD |
RAF1_HUMAN | ZYX_HUMAN | kinase -> substrate | Robert H Newman (2013) |
RAF1_HUMAN | PRDX1_HUMAN | kinase -> substrate | Robert H Newman (2013) |
RAF1_HUMAN | TIM23_HUMAN | kinase -> substrate | Robert H Newman (2013) |
AAPK2_HUMAN | RAF1_HUMAN | kinase -> substrate | RegPhos |
PAK2_HUMAN | RAF1_HUMAN | kinase -> substrate | RegPhos |
RAF1_HUMAN | CSDE1_HUMAN | kinase -> substrate | Robert H Newman (2013) |
MK08_HUMAN | RAF1_HUMAN | kinase -> substrate | KEGG |
RAF1_HUMAN | SOX10_HUMAN | kinase -> substrate | Robert H Newman (2013) |
RAF1_HUMAN | HCLS1_HUMAN | kinase -> substrate | Robert H Newman (2013) |
RAF1_HUMAN | BPL1_HUMAN | kinase -> substrate | Robert H Newman (2013) |
RHEB_HUMAN | RAF1_HUMAN | kinase -> substrate | HPRD |
RAF1_HUMAN | ASAP3_HUMAN | kinase -> substrate | Robert H Newman (2013) |
RAF1_HUMAN | NDF1_HUMAN | kinase -> substrate | Robert H Newman (2013) |
RAF1_HUMAN | SRXN1_HUMAN | kinase -> substrate | Robert H Newman (2013) |
JAK2_HUMAN | RAF1_HUMAN | kinase -> substrate | RegPhos |
KSR1_HUMAN | RAF1_HUMAN | kinase -> substrate | RegPhos |
RAF1_HUMAN | E2AK2_HUMAN | kinase -> substrate | Robert H Newman (2013) |
KPCA_HUMAN | RAF1_HUMAN | kinase -> substrate | KEGG; HPRD |
ZAGL2_HUMAN | RAF1_HUMAN | kinase -> substrate | RegPhos |
RAF1_HUMAN | IF4H_HUMAN | kinase -> substrate | Robert H Newman (2013) |
RAF1_HUMAN | RAF1_HUMAN | kinase -> substrate | RegPhos |
SRC_HUMAN | RAF1_HUMAN | kinase -> substrate | HPRD; RegPhos |
RAF1_HUMAN | OTU7B_HUMAN | kinase -> substrate | Robert H Newman (2013) |
RAF1_HUMAN | AAKG3_HUMAN | kinase -> substrate | Robert H Newman (2013) |
RAF1_HUMAN | PHAX_HUMAN | kinase -> substrate | Robert H Newman (2013) |
RAF1_HUMAN | BFAR_HUMAN | kinase -> substrate | Robert H Newman (2013) |
AKT1_HUMAN | RAF1_HUMAN | kinase -> substrate | HPRD; RegPhos |
RAF1_HUMAN | PP1R8_HUMAN | kinase -> substrate | Robert H Newman (2013) |
AAPK1_HUMAN | RAF1_HUMAN | kinase -> substrate | HPRD |
RAF1_HUMAN | KCRM_HUMAN | kinase -> substrate | Robert H Newman (2013) |
PKN1_HUMAN | RAF1_HUMAN | kinase -> substrate | RegPhos; Robert H Newman (2013) |
RAF1_HUMAN | MK01_HUMAN | kinase -> substrate | HPRD; RegPhos |
PAK3_HUMAN | RAF1_HUMAN | kinase -> substrate | HPRD; RegPhos |
MP2K1_HUMAN | RAF1_HUMAN | kinase -> substrate | NetPath |
RAF1_HUMAN | MP2K2_HUMAN | kinase -> substrate | KEGG |
RAF1_HUMAN | SYSC_HUMAN | kinase -> substrate | Robert H Newman (2013) |
RAF1_HUMAN | IF4B_HUMAN | kinase -> substrate | Robert H Newman (2013) |
RAF1_HUMAN | MTA1_HUMAN | kinase -> substrate | Robert H Newman (2013) |
MPIP1_HUMAN | RAF1_HUMAN | phosphatase -> substrate | HPRD |
RRAS2_HUMAN | RAF1_HUMAN | other | KEGG |
KPCA_HUMAN | RAF1_HUMAN | other | KEGG |
RAF1_HUMAN | MP2K1_HUMAN | other | KEGG |
RASH_HUMAN | RAF1_HUMAN | other | KEGG |
Function Annotation |
KEGG Pathway |
KEGG ID | Pathway |
---|---|
hsa05212 | Pancreatic cancer |
hsa04510 | Focal adhesion |
hsa04664 | Fc epsilon RI signaling pathway |
hsa04910 | Insulin signaling pathway |
hsa05223 | Non-small cell lung cancer |
hsa04540 | Gap junction |
hsa05220 | Chronic myeloid leukemia |
hsa04730 | Long-term depression |
hsa05210 | Colorectal cancer |
hsa04650 | Natural killer cell mediated cytotoxicity |
hsa04914 | Progesterone-mediated oocyte maturation |
hsa04810 | Regulation of actin cytoskeleton |
hsa05152 | Tuberculosis |
hsa05219 | Bladder cancer |
hsa04916 | Melanogenesis |
hsa05214 | Glioma |
hsa04726 | Serotonergic synapse |
hsa05034 | Alcoholism |
hsa05218 | Melanoma |
hsa04912 | GnRH signaling pathway |
hsa04270 | Vascular smooth muscle contraction |
hsa04010 | MAPK signaling pathway |
hsa04062 | Chemokine signaling pathway |
hsa04720 | Long-term potentiation |
hsa04370 | VEGF signaling pathway |
hsa05213 | Endometrial cancer |
hsa04660 | T cell receptor signaling pathway |
hsa05215 | Prostate cancer |
hsa04012 | ErbB signaling pathway |
hsa05160 | Hepatitis C |
hsa05200 | Pathways in cancer |
hsa04722 | Neurotrophin signaling pathway |
hsa04662 | B cell receptor signaling pathway |
hsa05164 | Influenza A |
hsa04666 | Fc gamma R-mediated phagocytosis |
hsa05211 | Renal cell carcinoma |
hsa05221 | Acute myeloid leukemia |
Gene Ontology |
GO ID | GO_Term | Evidence | Ontology |
---|---|---|---|
GO:0000186 | activation of MAPKK activity | TAS | biological_process |
GO:0007411 | axon guidance | TAS | biological_process |
GO:0008285 | negative regulation of cell proliferation | IDA | biological_process |
GO:0004674 | protein serine/threonine kinase activity | IDA | molecular_function |
GO:0005515 | protein binding | IPI | molecular_function |
GO:0046872 | metal ion binding | IEA | molecular_function |
GO:2000145 | regulation of cell motility | TAS | biological_process |
GO:0005737 | cytoplasm | ISS | cellular_component |
GO:0004709 | MAP kinase kinase kinase activity | IEA | molecular_function |
GO:0033138 | positive regulation of peptidyl-serine phosphoryla | IDA | biological_process |
GO:0005886 | plasma membrane | IEA | cellular_component |
GO:0016772 | transferase activity, transferring phosphorus-cont | IEA | molecular_function |
GO:0035556 | intracellular signal transduction | IEA | biological_process |
GO:0000165 | MAPK cascade | IEA | biological_process |
GO:0005737 | cytoplasm | IEA | cellular_component |
GO:0007264 | small GTPase mediated signal transduction | TAS | biological_process |
GO:0043154 | negative regulation of cysteine-type endopeptidase | TAS | biological_process |
GO:0007165 | signal transduction | TAS | biological_process |
GO:0030168 | platelet activation | TAS | biological_process |
GO:0042981 | regulation of apoptotic process | TAS | biological_process |
GO:0005057 | receptor signaling protein activity | IEA | molecular_function |
GO:0001666 | response to hypoxia | IEA | biological_process |
GO:0000186 | activation of MAPKK activity | IEA | biological_process |
GO:0007010 | cytoskeleton organization | IEA | biological_process |
GO:0004672 | protein kinase activity | TAS | molecular_function |
GO:0005634 | nucleus | IEA | cellular_component |
GO:0048011 | nerve growth factor receptor signaling pathway | TAS | biological_process |
GO:0006468 | protein phosphorylation | IEA | biological_process |
GO:0000165 | MAPK cascade | TAS | biological_process |
GO:0031143 | pseudopodium | IEA | cellular_component |
GO:0005886 | plasma membrane | TAS | cellular_component |
GO:0042060 | wound healing | TAS | biological_process |
GO:0035023 | regulation of Rho protein signal transduction | TAS | biological_process |
GO:0031434 | mitogen-activated protein kinase kinase binding | IEA | molecular_function |
GO:0008283 | cell proliferation | TAS | biological_process |
GO:0007268 | synaptic transmission | TAS | biological_process |
GO:0046982 | protein heterodimerization activity | IEA | molecular_function |
GO:0008286 | insulin receptor signaling pathway | TAS | biological_process |
GO:0004713 | protein tyrosine kinase activity | IEA | molecular_function |
GO:0043066 | negative regulation of apoptotic process | IDA | biological_process |
GO:0008543 | fibroblast growth factor receptor signaling pathwa | TAS | biological_process |
GO:0005515 | protein binding | IEA | molecular_function |
GO:0006915 | apoptotic process | IEA | biological_process |
GO:0006468 | protein phosphorylation | TAS | biological_process |
GO:0031333 | negative regulation of protein complex assembly | IDA | biological_process |
GO:0005741 | mitochondrial outer membrane | TAS | cellular_component |
GO:0006915 | apoptotic process | TAS | biological_process |
GO:0042802 | identical protein binding | IPI | molecular_function |
GO:0007173 | epidermal growth factor receptor signaling pathway | TAS | biological_process |
GO:0007507 | heart development | IEA | biological_process |
GO:0007596 | blood coagulation | TAS | biological_process |
GO:0007190 | activation of adenylate cyclase activity | NAS | biological_process |
GO:0048011 | nerve growth factor receptor signaling pathway | IEA | biological_process |
GO:0005524 | ATP binding | IEA | molecular_function |
GO:0005829 | cytosol | TAS | cellular_component |
GO:0007265 | Ras protein signal transduction | TAS | biological_process |
GO:0017016 | Ras GTPase binding | IEA | molecular_function |
GO:0045595 | regulation of cell differentiation | TAS | biological_process |